By JESSICA DaMASSA, WTF HEALTH
Click Therapeutics is a digital therapeutics company that develops and commercializes “software as medical treatments” — basically building digital formularies of prescribable software tools the same way a traditional pharma company would create a formulary of prescription drugs. CEO David Benshoof Klein stops by to talk about Click’s array of solutions and the support they’ve received from those traditional pharma companies, including investment from Sanofi-Genzyme BioVentures (which led their last funding round of $27.4M in October 2018) and a new partnership with Otsuka America, Inc. to fully fund development of an app to combat Major Depressive Disorder.
Filmed at Frontiers Health in Berlin, Germany, November 2019.
The post The Digital Therapeutics Startup Following Pharma’s Formulary Model | David Klein, Click Therapeutics appeared first on The Health Care Blog.